Senior insider sale
Chief Financial Officer at ARCUS BIOSCIENCES, INC. — senior position signals high conviction
$656.9K
29.21K shares
What this filing means
GOELTZ II ROBERT C. plans to sell 29.21K shares of ARCUS BIOSCIENCES, INC. valued at approximately $656.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/31/2025ACC: 0001628280-25-059249
Officer· Chief Financial Officer
Since Aug 2020
29.21K
Shares to sell
$656.9K
Approx. market value
6.55K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit
Equity Compensation
12/15/2025
6.55KTotal acquired6.55K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2025 | Restricted Stock Unit Equity Compensation | 6.55K | — |
| Total | 6.55K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
5.96K
Market value
$132.1K
12/17/2025
—Completed
Units to sell
6.70K
Market value
$146.7K
12/16/2025
—Completed
Units to sell
5K
Market value
$125.0K
11/26/2025
—Completed
Units to sell
5K
Market value
$100.0K
10/28/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
6.55K
Market value
$153.2K
12/31/2025
Total
Units
29.21K
Value
$656.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/17/2025 | 5.96K | $132.1K | — | Completed |
12/16/2025 | 6.70K | $146.7K | — | Completed |
11/26/2025 | 5K | $125.0K | — | Completed |
10/28/2025 | 5K | $100.0K | — | Completed |
| Planned — Approximate Date | ||||
12/31/2025 | 6.55K | $153.2K | NYSE | Planned |
| Total | 29.21K | $656.9K | ||